Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.435 HKD | +17.57% | +20.83% | -29.84% |
04-12 | Clover Biopharmaceuticals, Ltd. announced that it has received $0.320713 million in funding | CI |
04-08 | Clover Biopharmaceuticals' RSV Vaccine Candidate Shows Promise in Early Trial | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationQuarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-29.84% | 61.39M | |
-1.43% | 103B | |
+8.96% | 101B | |
+4.40% | 23.07B | |
-12.15% | 22.23B | |
-4.36% | 18.05B | |
-39.98% | 17.18B | |
-10.04% | 16.94B | |
+6.79% | 14.07B | |
+38.61% | 12.35B |
- Stock Market
- Equities
- 2197 Stock
- News Clover Biopharmaceuticals, Ltd.
- Clover Biopharmaceuticals' COVID-19 Booster Candidate Neutralizes Omicron Subvariant in Phase 3 Trial